1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA02714282
Company is developing technology that can specifically and potently silence disease-causing genes. The Company has a number of siRNA drugs and uses Tekmkira's LNP delivery patents. • Opko Health (OPK US) — the Company is involved in the discovery, development, and commercialization of pharmaceuticals p
No connected entities